Amgen News
Amgen To Present At The UBS Global Life Sciences Conference
PR Newswire May 16THOUSAND OAKS, Calif., May 16, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will participate in the UBS Global Life Sciences Conference on Tuesday, May 21, 2013, at the Sheraton New York Times Square in New ...
AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward
May 16TheStreet Ratings group highlights 5 stocks pushing the health care sector lower today.
Sanofi and Regeneron's Latest Partnership
Fool May 15Late-stage clinical trials begin for this duo's experimental rheumatoid arthritis drug.
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
PR Newswire May 15THOUSAND OAKS, Calif., May 15, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from three analyses of Vectibix ® (panitumumab) in combination with FOLFOX, an oxaliplatin-based chemotherapy ...
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
PR Newswire May 15THOUSAND OAKS, Calif., May 15, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present data from several studies of both pipeline and marketed products at the 2013 American Society ...
Sanofi/REGN Commence Enrollment - Analyst Blog
Zacks May 15Sanofi and Regeneron Pharma announced that they started enrolling patients for two phase III trials
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AMGN | 105.63 | +0.66 | +0.63% | 79.22B |
